Trio Health

Leveraging Real World Evidence to Achieve Clinical and Commercial Excellence

[Trio Health @TrioHealthInc]

We're excited to share our 5th poster from #ISPOR2023 showcasing research in #RA.

[Trio Health @TrioHealthInc]

@TrioHealthInc is pleased to present our 4th poster at #ISPOR2023. 'Are Biosimilars Equivalent to Originator Molecules in the Real World?' #rheumatoidarthritis

[Trio Health @TrioHealthInc]

'Towards Better Rheumatoid Arthritis Management' presented at #ISPOR2023

[Trio Health @TrioHealthInc]

2nd poster presented at #ISPOR2023 on Monday, 5/8/2023. #RA

[Trio Health @TrioHealthInc]

Proud to be presenting at #ISPOR2023 in Boston! #HAE

[Trio Health @TrioHealthInc]

Trio Health is thrilled to announce our partnership with Komodo Health on MapEnhance, a network of speciality data partners, including Trio, that seamlessly connect into Komodo’s tech platform, redefining the paradigm for RWD.

Read more here: https://t.co/xGjOtcuoCp

[Trio Health @TrioHealthInc]

Proud to be presenting at #IWHOD 2023!

[Trio Health @TrioHealthInc]

What Influences Switching to DTG/3TC vs B/F/TAF in Clinical Practice? Presenting at #CROI2023!

[Trio Health @TrioHealthInc]

Finishing up at #ACR2022, Trio Health and @AmericanRheum presenting the development of a national data repository of @AmericanRheum patients with systematic chart reviews to study/identify the factors impacting clinical effectiveness of Rheumatic disease treatment.

[Trio Health @TrioHealthInc]

At #ACR2022, Trio Health and @AmericanRheum are presenting comparisons of same-day CDAI and RAPID3 scores during treatment and at treatment discontinuation. Are they aligned and are they indicative of disease management?

[Trio Health @TrioHealthInc]

Trio Health and @AmericanRheum highlighting research on early discontinuation of b/tsDMARD treatment at #ACR2022.

[Trio Health @TrioHealthInc]

Trio Health and the Consortium of Independent Immunology Clinics detailing #HAE Registry insights into #HAE attack location/severity/resolution at #ACAAI22.

[Trio Health @TrioHealthInc]

Trio Health and Consortium of Independent Immunology Clinics sharing our work in forming US-based HAE patient registry at #ACAAI22. Thank you to Dr. William Lumry for presenting this Saturday, 11/12/2022!

[Trio Health @TrioHealthInc]

Celebrating another outstanding HIV PreP research contribution @HIVGlasgow by Janna Radtchenko and Dr. Rick Elion. Kudos!

[Trio Health @TrioHealthInc]

Congratulations to Janna Radtchenko and Dr. Rick Elion for their outstanding contributions to HIV research being presented @HIVGlasgow ! Well done!

[Trio Health @TrioHealthInc]

It's #IDWeek2022 and we're excited to have Dr. Richard Elion presenting our poster tomorrow! Congrats also to Janna Radtchenko.

[Trio Health @TrioHealthInc]

Exciting to share Trio research being published! This article compares real world utilization and effectiveness of Adynovate and Hemlibra in patients with moderate to severe Hemophilia A".
View here: https://t.co/AAOlAeymv3

[Trio Health @TrioHealthInc]

Announcing strategic partnership with Allergy Partners PLLC to form a national allergy and asthma patient registry. #asthma #allergy
Press Release here: https://t.co/NSqJkAb1bg